Business / Finance

RSS

Thermo Fisher to sell Athena Diagnostics and Lancaster Labs businesses for $940 million

Thermo Fisher Scientific Inc., the world leader in serving science, announced today that it has signed definitive agreements to sell its Athena Diagnostics and Lancaster Laboratories businesses for a total of $940 million in cash.

From Thermo Fisher Scientific Inc. 24 Feb 2011

Bruker to acquire Michrom Bioresources

Bruker today announced that it has signed an agreement to acquire Michrom Bioresources, Inc., a 20 year old, privately owned company based in Auburn, California. Michrom provides liquid chromatography instrumentation, accessories, and consumables for applications in the life science, chemical and applied markets.

24 Feb 2011

Integra LifeSciences fourth quarter revenues increase 6% to $10.6 million

Integra LifeSciences Holdings Corporation today reported its financial results for the fourth quarter and full year ending December 31, 2010. Total revenues for the fourth quarter were $194.1 million, reflecting an increase of $10.6 million, or 6%, over the fourth quarter of 2009.

24 Feb 2011

BRI and Eureka Genomics form strategic alliance to advance cancer treatments

Baylor Research Institute (BRI), the research arm of Baylor Health Care System, and bioinformatics pioneer Eureka Genomics (EG) have formed a strategic alliance to achieve a better understanding of the causes of colorectal cancer, potentially leading to advancements in the disease's prevention, management and treatment.

24 Feb 2011

ImmunoCellular to receive gross proceeds of $8.1M from sale of 5.2M units

ImmunoCellular Therapeutics, Ltd., announced it has entered into securities purchase agreements with certain institutional and other investors in connection with a private placement financing.

24 Feb 2011

CollaborativeCARE Conference, HIMSS form alliance to lead healthcare information technology

CollaborativeCARE Conference (C3), the first healthcare conference designed to foster regional coordinated care by educating specialists, primary care physicians and patients, today announced an alliance with HIMSS that will provide customized access to health information technology at the inaugural C3 event in Long Beach, Calif., scheduled for Nov. 15-20, 2011.

24 Feb 2011

EpiCept 2010 fourth quarter net loss is $0.06 per share

EpiCept Corporation today announced operating and financial results for the fourth quarter and full year ended December 31, 2010, and provided an update on its key business initiatives.

24 Feb 2011

Western Pistachio Association partners with USDA's MyPyramid

Western Pistachio Association (WPA) today announced its official partnership with USDA's MyPyramid, ramping up the WPA's nutrition educational programs to coincide with the announcement of the new 2010 Dietary Guidelines for Americans (DGA). The announcement was made at the WPA Annual Conference in Santa Barbara before more than 500 attendees, the majority of whom are growers in the American pistachio industry.

24 Feb 2011

Xenogenics retains Emmes to assist with development, execution of its capital formation strategy

Xenogenics Corporation, a majority owned subsidiary of MultiCell Technologies, Inc., is pleased to announce it has retained the Emmes Group to assist with the development and execution of its capital formation strategy to help finance expanded human clinical trials of its Ideal BioStent.

24 Feb 2011

Pharmagesic to acquire WEX shares

Pharmagesic Inc. announced today that the offer by its wholly-owned subsidiary, 7735308 Canada Limited to acquire all of the outstanding restricted voting shares of WEX Pharmaceuticals Inc. not already owned by Pharmagesic for C$0.14 cash per WEX Share has been extended to 5:00 p.m. on March 10, 2011.

23 Feb 2011

GTCR to acquire Sterigenics International

GTCR, a leading private equity firm, today announced it has signed a definitive agreement with Silverfleet Capital and PPM America Capital Partners to acquire Sterigenics International, the leading global provider of contract sterilization and ionization services for medical devices, food products, and advanced applications.

23 Feb 2011

Intercell places EUR 33.0m of Senior Unsecured Convertible Notes in private placement transaction

Intercell AG today announced that it successfully placed EUR 33.0m of Senior Unsecured Convertible Notes in a private placement transaction, which was increased due to investor demand.

23 Feb 2011

PPD, Elan establish strategic collaboration to execute clinical programs

Elan, plc and PPD, Inc. today announced they have formed a global business collaboration focused on the advancement, progression and execution of Elan's development portfolio.

23 Feb 2011

Town Sports fourth quarter total revenue decreases 0.2%

Town Sports International Holdings, Inc., a leading owner and operator of health clubs located primarily in major cities from Washington, DC north through New England, operating under the brand names "New York Sports Clubs," "Boston Sports Clubs," "Washington Sports Clubs" and "Philadelphia Sports Clubs," announced its results for the fourth quarter and full-year ended December 31, 2010.

23 Feb 2011

Gilead Sciences signs definitive agreement to acquire Calistoga for $375 million

Gilead Sciences, Inc. and Calistoga Pharmaceuticals, Inc., a privately-held biotechnology company focused on the development of medicines to treat cancer and inflammatory diseases, today announced the signing of a definitive agreement pursuant to which Gilead will acquire Calistoga for $375 million.

22 Feb 2011

Forest Labs enters definitive merger agreement to acquire Clinical Data

Forest Laboratories, Inc. and Clinical Data, Inc. today announced that they have entered into a definitive merger agreement pursuant to which Forest will acquire Clinical Data, a specialty pharmaceutical company focused on the development of first-in-class and best-in-category therapeutics, for $30.00 per share in cash plus contingent consideration of up to $6.00 per share that may be paid upon achievement of certain commercial milestones related to Viibryd.

22 Feb 2011

Henry Schein fourth quarter net sales increase 15.1% to $7.5 billion

Henry Schein, Inc., the largest provider of healthcare products and services to office-based practitioners, today reported record financial results for the quarter ended December 25, 2010.

22 Feb 2011

NHC announces net income of $3.22 per share for year ended Dec. 31, 2010

National HealthCare Corporation, one of the nation's oldest long-term health care companies, today announced net income available to common shareholders of $44,022,000 or $3.22 per share basic for the year ended Dec. 31, 2010, compared to $31,376,000 or $2.31 per share basic for the year ended Dec. 31, 2009, an increase of 40.3%.

22 Feb 2011

Johnson & Johnson completes cash tender for Crucell shares, declares offer unconditional

Johnson & Johnson and Crucell N.V. today announce that Johnson & Johnson has completed the tender offer for Crucell N.V. and has declared the offer unconditional.

22 Feb 2011

Kronos announces additional details regarding pending acquisition of API Healthcare at HIMSS conference

Kronos Incorporated today announced additional details regarding its pending acquisition of API Healthcare Corporation to organizations attending the HIMSS conference being held this week. The closing of the transaction is subject to regulatory approval and customary closing conditions.

22 Feb 2011